Ito, Eri
Overview
| Works: | 14 works in 18 publications in 3 languages and 33 library holdings |
|---|---|
| Roles: | Author, Other, Editor, Contributor |
Publication Timeline
.
Most widely held works by
Eri Ito
Development of zeolite catalysts for NOx reduction with NH3 in diesel exhaust gas by
Eri Ito(
Book
)
4 editions published in 1996 in English and held by 10 WorldCat member libraries worldwide
4 editions published in 1996 in English and held by 10 WorldCat member libraries worldwide
Josei ga ishi ni "undō shinasai" to iwaretara saisho ni yomu hon by
Jēmuzu Shūichi Nakano(
Book
)
2 editions published between 2019 and 2020 in Korean and Japanese and held by 4 WorldCat member libraries worldwide
2 editions published between 2019 and 2020 in Korean and Japanese and held by 4 WorldCat member libraries worldwide
Plasma cell panniculitis, a type of morphea profunda, surrounded by congenital nevus spilus by Chihiro Shiiya(
)
1 edition published in 2016 in English and held by 2 WorldCat member libraries worldwide
1 edition published in 2016 in English and held by 2 WorldCat member libraries worldwide
Ratio of blood urea nitrogen to serum creatinine at initiation of dialysis is associated with mortality: a multicenter prospective
cohort study by AICOPP group(
)
1 edition published in 2017 in English and held by 2 WorldCat member libraries worldwide
1 edition published in 2017 in English and held by 2 WorldCat member libraries worldwide
Aortic stenosis is a risk factor for all-cause mortality in patients on dialysis: a multicenter prospective cohort analysis by Tokai Aortic Stenosis in Dialysis Patients Cohort Study Group(
)
1 edition published in 2018 in English and held by 2 WorldCat member libraries worldwide
1 edition published in 2018 in English and held by 2 WorldCat member libraries worldwide
Combination Therapy with Renin-Angiotensin System Blockers and Vitamin D Receptor Activators for Predialysis Patients Is Associated
with the Incidence of Cardiovascular Events after Dialysis Initiation: A Multicenter Nonrandomized Prospective Cohort Study by Daijo Inaguma(
)
1 edition published in 2017 in English and held by 2 WorldCat member libraries worldwide
1 edition published in 2017 in English and held by 2 WorldCat member libraries worldwide
Impact of high mortality in incident dialysis patients due to hypertensive nephrosclerosis: a multicenter prospective cohort
study in Aichi, Japan by AICOPP Group(
)
1 edition published in 2018 in English and held by 2 WorldCat member libraries worldwide
1 edition published in 2018 in English and held by 2 WorldCat member libraries worldwide
Effect of combined vitamin D receptor activator and lanthanum carbonate on serum fibroblast growth factor 23 level in predialysis
patients (CVD-LAF study): design and method by
Eri Ito(
)
1 edition published in 2018 in English and held by 2 WorldCat member libraries worldwide
1 edition published in 2018 in English and held by 2 WorldCat member libraries worldwide
Factors associated with early failure of vascular access in acute-phase patients by
Akihito Tanaka(
)
1 edition published in 2016 in English and held by 2 WorldCat member libraries worldwide
1 edition published in 2016 in English and held by 2 WorldCat member libraries worldwide
Fp623early introduction of intravenous vdra could be associated with better prognosis of end-stage kidney disease patients
on hemodialysis(
)
1 edition published in 2018 in English and held by 1 WorldCat member library worldwide
1 edition published in 2018 in English and held by 1 WorldCat member library worldwide
Yi sheng shuo "qing ni yun dong!" shi, zui qiang dui zheng yun dong zhi nan : Riben shou xi ti neng xun lian shi jiao ni :
1 ci 5 fen zhong, shi fang shen ti suan tong pi lao, jiang zhong feng, xin zang bing si wang lu! by
Jēmuzu shūichi Nakano(
Book
)
1 edition published in 2020 in Japanese and held by 1 WorldCat member library worldwide
1 edition published in 2020 in Japanese and held by 1 WorldCat member library worldwide
Fp379relationship between serum alkaline phosphatase level at dialysis initiation and all-cause mortality: a multicenter,
prospective study(
)
1 edition published in 2018 in English and held by 1 WorldCat member library worldwide
1 edition published in 2018 in English and held by 1 WorldCat member library worldwide
Hydroxyurea-induced amyopathic dermatomyositis presenting with heliotrope erythema by
Eri Ito(
)
1 edition published in 2014 in Undetermined and held by 1 WorldCat member library worldwide
Hydroxyurea (HU) is a chemotherapeutic agent used for the treatment of myeloproliferative disorders such as chronic myeloid leukemia, polycythemia vera, and essential thrombocytosis. We describe a 69-year-old man who had essential thrombocytosis and developed amyopathic dermatomyositis after long-term HU therapy. He presented with Gottron papules and heliotrope erythema. The former has been described in all cases of HU-induced dermatomyositis; the latter has been seen in a few cases of that disorder
1 edition published in 2014 in Undetermined and held by 1 WorldCat member library worldwide
Hydroxyurea (HU) is a chemotherapeutic agent used for the treatment of myeloproliferative disorders such as chronic myeloid leukemia, polycythemia vera, and essential thrombocytosis. We describe a 69-year-old man who had essential thrombocytosis and developed amyopathic dermatomyositis after long-term HU therapy. He presented with Gottron papules and heliotrope erythema. The former has been described in all cases of HU-induced dermatomyositis; the latter has been seen in a few cases of that disorder
Hydroxyurea-induced amyopathic dermatomyositis presenting with heliotrope erythema by
Eri Ito(
)
1 edition published in 2014 in Undetermined and held by 1 WorldCat member library worldwide
Hydroxyurea (HU) is a chemotherapeutic agent used for the treatment of myeloproliferative disorders such as chronic myeloid leukemia, polycythemia vera, and essential thrombocytosis. We describe a 69-year-old man who had essential thrombocytosis and developed amyopathic dermatomyositis after long-term HU therapy. He presented with Gottron papules and heliotrope erythema. The former has been described in all cases of HU-induced dermatomyositis; the latter has been seen in a few cases of that disorder
1 edition published in 2014 in Undetermined and held by 1 WorldCat member library worldwide
Hydroxyurea (HU) is a chemotherapeutic agent used for the treatment of myeloproliferative disorders such as chronic myeloid leukemia, polycythemia vera, and essential thrombocytosis. We describe a 69-year-old man who had essential thrombocytosis and developed amyopathic dermatomyositis after long-term HU therapy. He presented with Gottron papules and heliotrope erythema. The former has been described in all cases of HU-induced dermatomyositis; the latter has been seen in a few cases of that disorder
more
fewer
Audience Level
| 0 |
 |
1 | ||
| General | Special | |||
Related Identities
- Inaguma, Daijo Other Author
- SpringerLink (Online service) Other
- Takahashi, Kazuo Other
- Hasegawa, Midori Other
- Yuzawa, Yukio Other
- Hayashi, Hiroki Other
- Koide, Shigehisa Other
- 中野ジェームズ修一 1971- Author
- AICOPP Group
- Yamane, Naoko Contributor